Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and Infants - Scorecard - MDSpire

Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and Infants

  • By

  • Hannah G Davies

  • Mary Kyohere

  • Valerie Tusubira

  • Alexander Amone

  • Amusa Wamawobe

  • Cleophas Komugisha

  • Philippa Musoke

  • Lauren Hookham

  • Pooja Ravji

  • Melanie Etti

  • Juliet Nsimire Sendagala

  • Dan R Shelley

  • Caitlin Farley

  • Merryn Voysey

  • Owen B Spiller

  • Joseph Peacock

  • Musa Sekikubo

  • Paul T Heath

  • Kirsty Le Doare

  • PROGRESS Study Author Group

  • Abdelmajid Djennad

  • Agnes Nyamaizi

  • Agnes Ssali

  • Alexander Amone

  • Amusa Wamawobe

  • Annettee Nakimuli

  • Caitlin Farley

  • Carol Nanyunja

  • Christine Najuka

  • Cleophas Komugisha

  • Dan R Shelley

  • Edward A R Portal

  • Ellie Duckworth

  • Emilie Karafillakis

  • Geraldine O’Hara

  • Godfrey Matovu

  • Hannah G Davies

  • Janet Seeley

  • Joseph Peacock

  • Juliet Nsimire Sendagala

  • Katie Cowie

  • Kirsty Le Doare

  • Konstantinos Karampatsas

  • Lauren Hookham

  • Madeleine Cochet

  • Margaret Sewegaba

  • Mary Kyohere

  • Maxensia Owor

  • Melanie Etti

  • Merryn Voysey

  • Moses Musooko

  • Musa Sekikubo

  • Owen B Spiller

  • Patience Atuhaire

  • Paul T Heath

  • Philippa Musoke

  • Phiona Nalubega

  • Pooja Ravji

  • Richard Katungye

  • Ritah Namugumya

  • Rosalin Parks

  • Rose Azuba

  • Sam Kipyeko

  • Simon Beach

  • Stephen Bentley

  • Tim Old

  • Tobius Mutabazi

  • Valerie Tusubira

  • Vicki Chalker

  • March 10, 2025

  • 0 min

Share

Clinical Scorecard: Investigation of Causes and Antimicrobial Resistance in Culture-Confirmed Infections Among Ugandan Infants: A Study Involving 7000 Neonates and Infants

At a Glance

CategoryDetail
ConditionNeonatal sepsis, pneumonia, and meningitis
Key MechanismsBacterial and viral infections causing bloodstream and respiratory tract infections; antimicrobial resistance to first-line antibiotics
Target PopulationNeonates and infants admitted with signs or risk factors for sepsis, pneumonia, or meningitis in Uganda
Care SettingTertiary hospitals in low-resource settings (Mulago National Referral Hospital and Kawempe National Referral Hospital, Kampala, Uganda)

Key Highlights

  • 11% of blood cultures and 8.6% of nasopharyngeal swabs were positive for pathogens among infants with suspected infection.
  • High inpatient mortality of 12.1%, with 27.7% case fatality among infants with Gram-negative bloodstream infections.
  • Almost 60% of Gram-negative pathogens showed resistance to WHO-recommended first-line antibiotics (ampicillin and gentamicin).

Guideline-Based Recommendations

Diagnosis

  • Use blood culture as the gold standard for identification of infective organisms in neonatal sepsis where available.
  • Collect nasopharyngeal swabs and cerebrospinal fluid (if indicated) for pathogen identification using PCR and standard microbiological testing.

Management

  • Empiric antibiotic therapy with gentamicin and benzylpenicillin or ampicillin for 7–10 days in neonates with serious bacterial infection.
  • Consider second-generation cephalosporins as second-line treatment in cases of treatment failure or resistance.

Monitoring & Follow-up

  • Monitor antimicrobial susceptibility patterns regularly to inform treatment guidelines.
  • Follow up infants until discharge or death to assess treatment outcomes.

Risks

  • High prevalence of antimicrobial resistance among Gram-negative pathogens reduces effectiveness of first-line antibiotics.
  • Increased mortality associated with Gram-negative bloodstream infections.

Patient & Prescribing Data

Neonates and infants admitted with signs or risk factors for sepsis, pneumonia, or meningitis in two Ugandan tertiary hospitals.

Empiric use of WHO-recommended antibiotics faces challenges due to high resistance rates; revised, context-specific antimicrobial guidelines are urgently needed.

Clinical Best Practices

  • Implement timely collection of blood cultures and other relevant specimens before antibiotic initiation when possible.
  • Use multiplex PCR assays to improve detection of viral and bacterial pathogens in respiratory infections.
  • Adapt antimicrobial treatment protocols based on local antimicrobial resistance surveillance data.
  • Prioritize infection prevention and control measures to reduce neonatal sepsis incidence and mortality.

References

Original Source(s)

Related Content